Keserű GM - Search Results

1

Controlling the selectivity of aminergic GPCR ligands from the extracellular vestibule.

Egyed A, Kelemen ÁA, Vass M, Visegrády A, Thee SA, Wang Z, de Graaf C, Brea J, Loza MI, Leurs R, Keserű GM. Egyed A, et al. Among authors: keseru gm. Bioorg Chem. 2021 Jun;111:104832. doi: 10.1016/j.bioorg.2021.104832. Epub 2021 Mar 19. Bioorg Chem. 2021. PMID: 33826962 Free article.

2

A neural network based virtual screening of cytochrome P450 3A4 inhibitors.

Molnar L, Keseru GM. Molnar L, et al. Among authors: keseru gm. Bioorg Med Chem Lett. 2002 Feb 11;12(3):419-21. doi: 10.1016/s0960-894x(01)00771-5. Bioorg Med Chem Lett. 2002. PMID: 11814811

3

Solid-phase synthesis of an N-(phenylalkyl)cinnamide library via Horner-Wadsworth-Emmons reaction.

Wéber C, Bielik A, Szendrei GI, Keserû GM, Greiner I. Wéber C, et al. Among authors: keseru gm. Bioorg Med Chem Lett. 2004 Mar 8;14(5):1279-81. doi: 10.1016/j.bmcl.2003.12.038. Bioorg Med Chem Lett. 2004. PMID: 14980681

4

Oxamides as novel NR2B selective NMDA receptor antagonists.

Barta-Szalai G, Borza I, Bozó E, Kiss C, Agai B, Proszenyák A, Keseru GM, Gere A, Kolok S, Galgóczy K, Horváth C, Farkas S, Domány G. Barta-Szalai G, et al. Among authors: keseru gm. Bioorg Med Chem Lett. 2004 Aug 2;14(15):3953-6. doi: 10.1016/j.bmcl.2004.05.053. Bioorg Med Chem Lett. 2004. PMID: 15225705

5

Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.

Agai-Csongor E, Nógrádi K, Galambos J, Vágó I, Bielik A, Magdó I, Ignácz-Szendrei G, Keseru GM, Greiner I, Laszlovszky I, Schmidt E, Kiss B, Sághy K, Laszy J, Gyertyán I, Zájer-Balázs M, Gémesi L, Domány G. Agai-Csongor E, et al. Among authors: keseru gm. Bioorg Med Chem Lett. 2007 Oct 1;17(19):5340-4. doi: 10.1016/j.bmcl.2007.08.015. Epub 2007 Aug 15. Bioorg Med Chem Lett. 2007. PMID: 17720494

6

Application of the BD ACTOne technology for the high-throughput screening of Gs-coupled receptor antagonists.

Visegrády A, Boros A, Némethy Z, Kiss B, Keseru GM. Visegrády A, et al. Among authors: keseru gm. J Biomol Screen. 2007 Dec;12(8):1068-73. doi: 10.1177/1087057107309035. J Biomol Screen. 2007. PMID: 18087071

7

Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.

Kiss R, Kiss B, Könczöl A, Szalai F, Jelinek I, László V, Noszál B, Falus A, Keseru GM. Kiss R, et al. Among authors: keseru gm. J Med Chem. 2008 Jun 12;51(11):3145-53. doi: 10.1021/jm7014777. Epub 2008 May 7. J Med Chem. 2008. PMID: 18459760

8

Histamine H4 receptor ligands and their potential therapeutic applications.

Kiss R, Keseru GM. Kiss R, et al. Among authors: keseru gm. Expert Opin Ther Pat. 2009 Feb;19(2):119-35. doi: 10.1517/13543770802691085. Expert Opin Ther Pat. 2009. PMID: 19441913 Review.

9

Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening.

Kiss R, Polgár T, Kirabo A, Sayyah J, Figueroa NC, List AF, Sokol L, Zuckerman KS, Gali M, Bisht KS, Sayeski PP, Keseru GM. Kiss R, et al. Among authors: keseru gm. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3598-601. doi: 10.1016/j.bmcl.2009.04.138. Epub 2009 May 5. Bioorg Med Chem Lett. 2009. PMID: 19447617 Free PMC article.

10

Hit-to-lead optimization of pyrrolo[1,2-a]quinoxalines as novel cannabinoid type 1 receptor antagonists.

Szabó G, Kiss R, Páyer-Lengyel D, Vukics K, Szikra J, Baki A, Molnár L, Fischer J, Keseru GM. Szabó G, et al. Among authors: keseru gm. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3471-5. doi: 10.1016/j.bmcl.2009.05.010. Epub 2009 May 7. Bioorg Med Chem Lett. 2009. PMID: 19457667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page